Rokit Healthcare to buy bankrupt Innopia Tech for $5.24M smart hospital push
What's the deal? Rokit Healthcare agreed to acquire 100% of InnopiaTechDealroom has a profile for this one. Try Dealroom →, a South Korean digital device maker in court-led rehabilitation, for US$5.87M. The deal, disclosed on November 16, buys 1.4 million new shares via a third-party allotment, with closing targeted for March 31, 2027.
What's the endgame? Rokit, an AI-based regenerative medicine company, wants to enter the US smart hospital market. InnopiaTech makes Android TVs, smart set-top boxes, and contactless vital-sign technology, and already supplies hospital-room solutions through a US partner.
What changes? Rokit plans to add its AI-Totalis 35 health engine — trained on data from about 250,000 people — to hospital-room TVs, letting patients check schedules, medication, and remote consultations on one screen. The goal is to convert one-off hardware sales into recurring software and subscription revenue, with plans to expand into the Middle East and Asia.
The numbers: InnopiaTech reported US$20M in revenue last year but a net loss of US$21.9M. Its liabilities of US$31.5M far exceeded assets of US$11M, leaving total equity at minus US$20.5M — full capital impairment — and its auditor issued a disclaimer of opinion.
What could go wrong? The deal needs approval from the rehabilitation court and the passage of a reorganisation plan; if conditions aren't met, it may be withdrawn or delayed. Rokit itself is under strain, with its third-quarter 2026 operating loss widening to US$7.96M.
The signal: The acquisition tests whether Rokit can stretch from regenerative medicine into subscription-based digital health. The strategy hinges on turning InnopiaTech's existing orders, worth about US$6.71M, into real hospital contracts and repeat revenue.
Read more: edaily.co.kr
Image credit: Generated with Gemini